Shares of FibroGen dropped by a staggering 47.82% in 30 days from $40.48 to $21.12 at 20:15 EST on Thursday, after two sequential sessions in a row of gains. NASDAQ Composite is falling 0.94% to $13,818.41, following last session’s upward trend,
FibroGen’s last close was $21.06, 170.88% below its 52-week high of $57.21.
The company’s growth estimates for the present quarter and the next is 2.2% and 51.6%, respectively.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $21.12 at 20:15 EST, way below its 52-week high of $57.21 and above its 52-week low of $20.51.
FibroGen’s Moving Average
FibroGen’s worth is way under its 50-day moving average of $39.14 and way below its 200-day moving average of $42.31.
More news about FibroGen.